Cetuximab Completed Phase 2 Trials for Head Neck Cancer Squamous Cell / Head and Neck Cancer Squamous Cell Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01237483Reirradiation and Erbitux in the HNSCC